AF Patient Decision Aid – Dr Yassir Javaid


This table was produced by Dr Yassir Javaid and is based on the likely risk/benefit of warfarin in AF patients. The NOACs have been shown to be at least non-inferior to warfarin in terms of reducing ischaemic stroke in AF patients. Dabigatran 150mg bd has been shown to be superior to warfarin in reducing ischaemic stroke.



More Tools

Atrial Fibrillation Advisor

The core template is a comprehensive guide designed to help you assess and inform patients with atrial fibrillation about the risks and benefits of anticoagulation.

Risk Calculator

This resource will allow you to produce a specific risk sheet for your patient based on their ...


GRASP-AF is a free, easy-to-use tool that assists GP practices to interrogate their clinical ...
This site is intended for Healthcare Professionals only

If you are not a healthcare professional, please Click Here